General MedicationsINJECTIONStandard
SELARSDI
USTEKINUMAB-AEKN
Standard Dose
90MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview SELARSDI is listed in Drugs@FDA under application 761343 (BLA).
Marketing status: Prescription Active ingredient USTEKINUMAB-AEKN Form and strength INJECTABLE;INJECTION - 90MG/ML Sponsor ALVOTECH USA INC Submission history Latest submission status date: 2025-12-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview SELARSDI is listed in Drugs@FDA under application 761343 (BLA). Marketing status: Prescription Active ingredient USTEKINUMAB-AEKN Form and strength INJECTABLE;INJECTION - 90MG/ML Sponsor ALVOTECH USA INC Submission history Latest submission status date: 2025-12-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.